Analysis of Gene Expression of PBMC in the Hepatitis C Virus Genotype 1b-infected Patients During Peg-interferon-α Plus Ribavirin Combination Therapy
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PBMC
- 11 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2015 Planned end date changed from 1 Oct 2009 to 1 Oct 2017 as reported by ClinicalTrials.gov.
- 01 Mar 2009 Planned end date changed from 1 Aug 2008 to 1 Oct 2009 as reported by ClinicalTrials.gov.